Data Driven Formulation Approaches for Oral Small Molecule Drugs
Key decisions made in early development impact a molecule’s long term success. This presentation examines the role of physicochemical and biopharmaceutical data in guiding early small molecule drug development decisions. This talk also discusses why solubility is only part of the equation when addressing a molecule’s bioavailability and potential success as an oral drug candidate.
- Relate physicochemical properties to the impact on solubility and bioavailability
- How to apply the Developability Classification System (DCS) to guide formulation design
- Importance of PBPK modeling to ensure the right molecule is under development